With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Ezekiel Emanuel, Vice Provost for Global Initiatives and Chair of the Department of Medical Ethics and Health Policy, University of Pennsylvania
Ole Norheim, Professor and Director of the Bergen Center for Ethics and Priority Setting, University of Bergen
Dean Jamison, Professor Emeritus, University of Washington and University of California, San Francisco
Joseph Millum, Bioethicist, Clinical Center Department of Bioethics & Fogarty International Center, US National Institutes of Health
Amanda Glassman, Executive Vice President and Senior Fellow, Center for Global Development
Peter Neumann, Professor of Medicine and Director, Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies, Tufts Medical Center
Carla Saenz, Regional Bioethics Advisor, Pan American Health Organization (PAHO)
ABOUT THE EVENT
The global health community strives to ensure that all people, regardless of who they are or where they live, can access quality health services without financial hardship. To meet the health-related SDGs and the commitments laid out in the 2019 United Nations High Level Meeting Declaration on Universal Health Coverage (UHC), many more billions of dollars will need to be spent on health. But as donors drawdown development assistance for many health programs, and as domestic funding for health grows at too slow a rate to close the financing gap in most countries, how should finite financial resources be spent to maximize health impact in a way that is ethically and economically justifiable?
The new book Global Health Priority Setting: Beyond Cost-Effectiveness, edited by Ole F. Norheim, Ezekiel J. Emanuel, and Joseph Millum, offers ethical reflections for how to think about priority setting in health in the era of UHC aspirations and provides new actionable frameworks and tools for use in the allocation of health care. Join the Center for Global Development to explore new ethical and economic insights into how money spent on health care can go further and tackle the most important questions that decisionmakers must consider in allocating health resources, centered around new contributions from ethicists, philosophers, economists, policymakers, and clinicians from around the world on setting national and global priorities in health.
Please join us for a reception following the event.
This web conference will gather an international panel of clinicians, academics, and policy makers to discuss the pressing priority-setting issues raised by COVID-19 around the world. We aim to learn from one another how best to navigate the ethical challenges every country faces.
Ghanaian Finance Minister, Ken Ofori-Atta, joins CGD President Masood Ahmed to discuss the impact of the COVID-19 pandemic in Africa, the state of the continent's response, and the challenges ahead. As Chair of the joint Bank-IMF Development Committee Minister Ofori-Atta has collaborated with his South African counterpart (current Chair of the African Union) to lead a joint African response to COVID19. After two virtual meetings under their leadership, the African Finance Ministers requested $100 billion in support, as well as debt relief, to deal with the economic fallout of the pandemic. How will the Development Committee meeting in two weeks advance that agenda? What lies ahead for Africa and for international development cooperation both during and beyond this unprecedented crisis?
Successful suppression of COVID-19 in the United States will require urgent and decisive action by state, local, and community leaders across the country. To support effective decision-making, top global health security leaders have released a COVID-19 Frontline Guide. Developed in response to calls from local governments for more information on how to protect their communities, the online tool features eight indicators of progress for self-assessment and seven key actions that each include checklists of decision points. The guide provides a framework to help local leaders establish effective strategies to fight the outbreak, both by reducing transmission of the disease and by supporting their communities effectively. The website and guide will be discussed at an online webinar on Tuesday, March 31 at 12:30 pm ET. Register below, and we will provide the Zoom information before the event.
Aid agencies are scrambling to adapt as the COVID-19 pandemic is felt throughout the world. Join TNH Senior Editor Ben Parker as he speaks to leading experts and practitioners from across the humanitarian sector to discuss some of the most pressing issues. How will COVID-19 impact crisis-affected and already-vulnerable communities? How is the humanitarian sector adjusting to life under the shadow of a new global pandemic? Where should priorities lie? And what does this crisis reflect about the changing face of vulnerability?
Novartis Access is a new line of mostly branded generic NCD medicines offered at a wholesale price of US$1 per treatment per month. Please join us for a seminar featuring Peter Rockers and Veronika Wirtz, who will present findings from recent and ongoing work examining Novartis Access in Kenya, the first country to receive the program. The researchers will first present evidence from a randomized controlled trial of the impact of Novartis Access on the price and availability of NCD medicines at health facilities and households. They will then present evidence from their latest analysis, which explores patient willingness-to-pay (WTP) for Novartis Access-branded generics compared to unbranded generic equivalents. The researchers will discuss their findings in light of current policy reforms in Kenya. Finally, the seminar will examine lessons learned from the RCT of Novartis Access and its potential implications for other pharmaceutical companies, along with the broader global health community, in developing and implementing programs to improve access to medicines.